Volume 11 (2024) | Issue 5
Volume 11 (2024) | Issue 5
Volume 11 (2024) | Issue 5
Volume 11 (2024) | Issue 5
Volume 11 (2024) | Issue 4
Background: Myasthenia gravis is a rare autoimmune disease caused by antibodies that probably originate from the thymus glands. In recent years, thymectomy has become a widespread procedure in the treatment of myasthenia gravis (MG). Transsternal approach with thymectomy is the accepted standard surgical approach for many years. Aim: To evaluate the outcomes of 60 patients who underwent thymectomy f